IQVIA Holdings Inc. (IQV)
IQVIA Holdings Inc. $IQV Shares Sold by Glenmede Investment Management LP
Glenmede Investment Management LP reduced its holdings in shares of IQVIA Holdings Inc. (NYSE: IQV) by 8.8% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 202,711 shares of the medical research company's stock after selling 19,677 shares during
IQVIA Holdings Inc. (IQV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
IQVIA Holdings Inc. (IQV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
IQVIA Holdings Inc. (IQV) Presents at Leerink Global Healthcare Conference 2026 Transcript
IQVIA Holdings Inc. (IQV) Presents at Leerink Global Healthcare Conference 2026 Transcript
IQVIA Holdings: Still Exceeding Expectations As A Stealth Compounder
IQVIA Holdings delivered strong Q4 and full-year 2025 results, confirming its leadership in data, analytics, and clinical execution. Despite macro headwinds and cautious biotech spending, IQV maintained robust profitability, near-100% cash conversion, and expanded its $32.7B backlog. EPS guidance for 2026 was below consensus, triggering a selloff, but I remain bullish due to durable bookings, backlog, and elite financial metrics.
IQVIA Holdings Inc. (IQV) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
IQVIA Holdings Inc. (IQV) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
Is the Options Market Predicting a Spike in IQVIA Stock?
Investors need to pay close attention to IQVIA stock based on the movements in the options market lately.
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript
IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript
IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y
IQV posted a fourth-quarter 2025 earnings and revenue beat with double-digit Y/Y sales growth, strong segment gains and upbeat 2026 revenue guidance.
IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates
IQVIA Holdings (IQV) came out with quarterly earnings of $3.42 per share, beating the Zacks Consensus Estimate of $3.4 per share. This compares to earnings of $3.12 per share a year ago.
IQV or IDXX: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Instruments stocks are likely familiar with IQVIA Holdings (IQV) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?
IQVIA Set to Report Q4 Earnings: Here's What You Should Know
IQV is set to report fourth-quarter 2025 earnings results on Feb. 5, with revenues expected to rally 7.2% y/y to $4.2B and EPS to rise 9% on segment growth.
